Will Cannabis Genetics Be Banned?
A redefinition of hemp under national law, scheduled to take place Nov. 12, spells the end of Farm Bill protections for numerous hemp-derived THC products across the nation: mild beverages as well as THCA flower and delta-8 THC edibles, vapes and additional products sold at gas stops and smoke shops.
But the hemp ban also creates a major complication for the legal cannabis industry. Seeds from cannabis cultivars that produce flower with more than 0.3% THC are no longer legal to transport out of state.
Although seed purchases will probably continue in authorized states, the modifications threaten to shutter some seed banks and genetics businesses, observers note, while creating supply-chain issues for cannabis cultivators and retailers.
"If this wording goes through, we will need pop-up stores to offer seeds in every state where it's permitted," Campanella said. "Which is why we're also providing clones and tissue culture, because that's not included in the bill."
When are cannabis genetics and clones prohibited to ship across state lines?
The new regulations classify seeds based on the THC potential of the parent plant. Genetic material such as seeds and clones are rendered illegal if the final product crosses the threshold.
For the moment, seeds are currently shipping under the 2018 Farm Bill's current quo. But the time is ticking for businesses like Brothers Grimm and for cannabis growers who fear supply chain disruptions if out-of-state access to genetics is prohibited.
Most of the cannabis industry remains largely unaware of the impending shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.
Without federal intervention in the form of an exception for seeds or an overall moratorium, many seed providers will simply be shuttered come November, he added.
"We are operating legally currently, but if that shifts, it will disrupt the legal licensed industry in each state," said Power, whose customers includes seed suppliers as well as licensed business cultivators.
"Consumers are going to forfeit choice, and it will be a significant shutdown for many people."
What are cannabis seed suppliers doing to remain legal after the government hemp ban?
Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis supervision in that state while also restricting hemp-derived THC products to licensed cannabis retailers.
Formerly a seed supplier, Silberhaze is currently focused on the marketing, preservation and IP safeguarding of elite plant genetics.
That's because seed businesses hoping to remain compliant in this new environment must have solid documentation, he said.
"You have to prove where this stuff comes from, so it's extremely important to have documentation, even to the point where you have breeder names," Silber said.
"Small businesses will have to work with improved records and a stronger chain of custody," he added. "We want that documentation too, because we don't want to be dealing with shady sources."
To avoid seizures and other legal fallout, seed entrepreneurs must "get their ducks in a row" before the updated regulations take effect, Silber said.
"Audit all your stuff immediately, and classify what you can," Silber said. "Take stock, document your lineage, preserve cultivator records, and arrange any cannabinoid or terpene information you currently have. If regulations shift, you'll be in a much better position to comprehend what may be impacted and make informed decisions."
Does federal marijuana rescheduling affect cannabis genetics?
Silber believes U.S. Drug Enforcement Administration licensing may be required for companies engaged in research.
But for the time being, https://nativesusa.com/ - seed companies can't enroll with the DEA like state-licensed medical cannabis businesses can. Such a pathway is not available to seed suppliers, nurseries or genetics businesses, said Jim Ickes, a lawyer and partner with Frantz Ward's cannabis practice group in Cleveland.
"Seed-related activity may be occurring inside larger state-licensed therapeutic marijuana operations, as some states permit dispensaries or registered medical operators to offer seeds, clones or home-cultivation materials," he said.
"But that is distinct from the DEA creating a freestanding seed bank registration category."
Some genetics companies are already changing business practices to comply with the updated law. According to Ickes, they must address questions including:
- Which of our varieties produce plants over 0.3% total THC?
- Which seeds remain as hemp after Nov. 12, 2026, and which don't?
- What does our inventory look like once we organize it against the viable-seed exclusion?
Ickes also understands confusion from clients who believed federal rescheduling of medical marijuana would resolve their situation with financial institutions. However, the recent regulatory wording has moved those conversations beyond the fundamentals of classification, he said.
"Financial institutions ask whether this particular revenue source is legal, whether it ties to state-licensed activity, or whether there's cross-state risk," said Ickes.
"After November, a seed bank selling high-THC genetics can't answer the initial question with the hemp definition. It has to point to a lawful state cannabis channel instead. Seed banks dealing in authentic industrial-hemp seed keep the cleaner story."
What's the future of cannabis genetics?
Campanella is a member of a emerging coalition of other breeders, growers and researchers that's arguing seeds are better defined as agricultural inputs than regulated substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, leaving the DEA to concentrate its enforcement efforts elsewhere.
"How do you regulate something based on what it might become one day?" said Campanella. "Our preference is to have that wording removed, or get seeds regulated by the USDA as a hemp product."
But in the interim, Campanella is reorganizing Brothers Grimm to function outside the reach of changing federal oversight. The business plans to keep its Colorado seed facility while positioning its Oklahoma tissue cultivation facility as a safeguard against government prohibition of cannabis seeds.
As she explained: "If things develop in a way where we can't focus on interstate shipping, we'll have additional resources to meet people's requirements without putting ourselves in trouble."
